AI Verdict
IMCR has stronger fundamentals based on our AI analysis.
IMDX vs IMCR Fundamental Comparison
| Metric | IMDX | IMCR |
|---|---|---|
| Revenue | $4.1M | $400.0M |
| Net Income | $-50.2M | $-35.5M |
| Net Margin | -1,238.5% | -8.9% |
| ROE | N/A | -9.3% |
| ROA | -195.0% | -3.3% |
| Current Ratio | 1.27x | 4.04x |
| Debt/Equity | N/A | 1.15x |
| EPS | $-1.65 | $-0.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMDX vs IMCR: Frequently Asked Questions
Is IMDX or IMCR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMCR has stronger fundamentals. IMDX is rated STRONG SELL (88% confidence) while IMCR is rated HOLD (65% confidence). This is not investment advice.
How does IMDX compare to IMCR fundamentally?
Insight Molecular Diagnostics Inc. has ROE of N/A vs Immunocore Holdings plc's -9.3%. Net margins are -1,238.5% vs -8.9% respectively.
Which stock pays higher dividends, IMDX or IMCR?
IMDX has a dividend yield of N/A or no dividend while IMCR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMDX or IMCR for long term?
For long-term investing, consider that IMDX has STRONG SELL rating with 88% confidence, while IMCR has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMDX vs IMCR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMDX vs IMCR, the AI consensus favors IMCR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.